Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer

G. Von Minckwitz; M. Procter; E. De Azambuja; D. Zardavas; M. Benyunes; G. Viale; T. Suter; A. Arahmani; N. Rouchet; E. Clark; A. Knott; I. Lang; C. Levy; D.A. Yardley; J. Bines; R.D. Gelber; M. Piccart; J. Baselga

doi:10.1056/NEJMoa1703643

Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer

G. Von Minckwitz, M. Procter, E. De Azambuja, D. Zardavas, M. Benyunes, G. Viale, T. Suter, A. Arahmani, N. Rouchet, E. Clark, A. Knott, I. Lang, C. Levy, D.A. Yardley, J. Bines, R.D. Gelber, M. Piccart, J. Baselga

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	122-131
Number of pages	10
Journal	New England Journal of Medicine
Volume	377
Issue number	2
DOIs	https://doi.org/10.1056/NEJMoa1703643
Publication status	Published - 2017

Access to Document

10.1056/NEJMoa1703643

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023170865&doi=10.1056%2fNEJMoa1703643&partnerID=40&md5=e064575f179e6f83a66d0c8c1bef7736

Cite this

Von Minckwitz, G., Procter, M., De Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., Knott, A., Lang, I., Levy, C., Yardley, D. A., Bines, J., Gelber, R. D., Piccart, M., & Baselga, J. (2017). Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer. New England Journal of Medicine, 377(2), 122-131. https://doi.org/10.1056/NEJMoa1703643

Von Minckwitz, G, Procter, M, De Azambuja, E, Zardavas, D, Benyunes, M, Viale, G, Suter, T, Arahmani, A, Rouchet, N, Clark, E, Knott, A, Lang, I, Levy, C, Yardley, DA, Bines, J, Gelber, RD, Piccart, M & Baselga, J 2017, 'Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer', New England Journal of Medicine, vol. 377, no. 2, pp. 122-131. https://doi.org/10.1056/NEJMoa1703643

@article{caf16e4372f445d7aef69d61435c5a0d,

title = "Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer",

author = "{Von Minckwitz}, G. and M. Procter and {De Azambuja}, E. and D. Zardavas and M. Benyunes and G. Viale and T. Suter and A. Arahmani and N. Rouchet and E. Clark and A. Knott and I. Lang and C. Levy and D.A. Yardley and J. Bines and R.D. Gelber and M. Piccart and J. Baselga",

note = "Cited By :41 Export Date: 7 March 2018",

year = "2017",

doi = "10.1056/NEJMoa1703643",

language = "English",

volume = "377",

pages = "122--131",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

TY - JOUR

T1 - Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer

AU - Von Minckwitz, G.

AU - Procter, M.

AU - De Azambuja, E.

AU - Zardavas, D.

AU - Benyunes, M.

AU - Viale, G.

AU - Suter, T.

AU - Arahmani, A.

AU - Rouchet, N.

AU - Clark, E.

AU - Knott, A.

AU - Lang, I.

AU - Levy, C.

AU - Yardley, D.A.

AU - Bines, J.

AU - Gelber, R.D.

AU - Piccart, M.

AU - Baselga, J.

N1 - Cited By :41 Export Date: 7 March 2018

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1703643

DO - 10.1056/NEJMoa1703643

M3 - Article

SN - 0028-4793

VL - 377

SP - 122

EP - 131

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -